全文获取类型
收费全文 | 5267篇 |
免费 | 388篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 39篇 |
儿科学 | 161篇 |
妇产科学 | 114篇 |
基础医学 | 809篇 |
口腔科学 | 75篇 |
临床医学 | 447篇 |
内科学 | 1440篇 |
皮肤病学 | 134篇 |
神经病学 | 584篇 |
特种医学 | 66篇 |
外科学 | 403篇 |
综合类 | 22篇 |
一般理论 | 3篇 |
预防医学 | 489篇 |
眼科学 | 117篇 |
药学 | 332篇 |
中国医学 | 42篇 |
肿瘤学 | 398篇 |
出版年
2023年 | 87篇 |
2022年 | 155篇 |
2021年 | 281篇 |
2020年 | 129篇 |
2019年 | 191篇 |
2018年 | 223篇 |
2017年 | 156篇 |
2016年 | 171篇 |
2015年 | 190篇 |
2014年 | 230篇 |
2013年 | 299篇 |
2012年 | 436篇 |
2011年 | 472篇 |
2010年 | 182篇 |
2009年 | 177篇 |
2008年 | 308篇 |
2007年 | 265篇 |
2006年 | 248篇 |
2005年 | 225篇 |
2004年 | 230篇 |
2003年 | 201篇 |
2002年 | 206篇 |
2001年 | 38篇 |
2000年 | 32篇 |
1999年 | 35篇 |
1998年 | 32篇 |
1997年 | 35篇 |
1996年 | 26篇 |
1995年 | 24篇 |
1994年 | 16篇 |
1993年 | 20篇 |
1992年 | 33篇 |
1991年 | 17篇 |
1990年 | 16篇 |
1989年 | 23篇 |
1988年 | 11篇 |
1987年 | 16篇 |
1986年 | 13篇 |
1985年 | 13篇 |
1984年 | 7篇 |
1982年 | 18篇 |
1981年 | 10篇 |
1980年 | 7篇 |
1979年 | 9篇 |
1977年 | 7篇 |
1976年 | 6篇 |
1975年 | 7篇 |
1968年 | 6篇 |
1938年 | 8篇 |
1927年 | 7篇 |
排序方式: 共有5675条查询结果,搜索用时 15 毫秒
81.
82.
83.
84.
C. Zanon R. Clara M. Bortolini A. Malossi R. Moscato P. Celoria M. De Andrea M. Rizzo I. Chiappino M. Grazia Sciuto A. Mussa 《International journal of hyperthermia》2013,29(5):456-464
ChemoHyperthermic Peritoneal Perfusion (CHPP) after cytoreductive surgery is a relatively new procedure in the treatment of abdominal carcinomatosis or sarcomatosis. An assessment of the CHPP technique performed on 20 patients suffering from abdominal malignancies was carried out. After surgical debulking and gastrointestinal anastomosis, two Tenckhoff catheters were positioned for the immediate performance of CHPP, which was carried out at 42-43°C for 1h, after closing the abdomen. In 19 assessable patients, 47.3% and 36.8% complete responses (CR) were recorded at 1 and 6 months, respectively, with responses of 37.5% in patients affected with gastrointestinal cancer and 50% in patients affected with ovarian cancer. CR were obtained only in patients who had undergone accurate peritoneal debulking. Survival rate for gastrointestinal and ovarian cancer was 68% at 12 months. Patients who underwent radical cytoreductive surgery are all alive at a follow-up median time of 17 months. Two anastomotic leakages with spontaneous recovery were observed, along with one hydrothorax, which was immediately drained during the procedure, three cases of chemotherapic gastrointestinal toxicity, one sepsis, one renal failure that required a transient dialysis, and one cholecystitis that required cholecystectomy. One patient died 30 days after CHPP of a cardiac ischaemia not strictly related to the surgical procedure. In the authors' experience, CHPP with closed abdomen after reconstructive gastrointestinal surgery is a safe and feasible treatment with acceptable side effects. 相似文献
85.
Peter Bergin Lynette Sadleir Benjamin Legros Zarine Mogal Manjari Tripathi Nitika Dang Simone Beretta Clara Zanchi Jorge Burneo Thomas Borkowski Yang Je Cho Michel Ossemann Pasquale Striano Kavita Srivastava Hui Jan Tan Jithangi Wanigasinghe Wendyl D’Souza for the EpiNet study group 《Epilepsia》2012,53(10):1829-1835
Purpose: We created an epilepsy patient database that can be accessed via the Internet by neurologists from anywhere in the world. The database was designed to enroll and follow large cohorts of patients with specific epilepsy syndromes, and to facilitate recruitment of patients for investigator‐initiated clinical trials. Methods: The EpiNet database records physician‐derived information regarding seizure type and frequency, epilepsy syndrome, etiology, drug history, and investigations. It can be accessed from any country by approved investigators via a secure, password‐protected Website. All data are encrypted. The database is for both research and clinical purposes. Investigators were invited to register any patient with epilepsy, but were particularly encouraged to register patients when uncertain of the optimal management. Participation required approval from investigators’ ethics committees and institutional review boards, and all patients or their caregiver provided written informed consent. Patients were not enrolled in clinical trials in this pilot study. Key Findings: The international pilot study recruited patients from September 2010 to November 2011. Sixty‐four investigators or research assistants from 25 centers in 13 countries registered 1,050 patients. Patients with a wide range of epilepsy syndromes and etiologies were registered. Patients’ ages ranged from 2 weeks to 90 years. Significance: The Website was successfully used by doctors working in different health systems. The pilot study confirmed that this low‐cost, collaborative approach to research has great potential. Large, multicenter cohort studies will commence in 2012, and randomized clinical trials are being planned. All epileptologists are invited to join this project. 相似文献
86.
87.
88.
89.
Clara Hjalmarsson Lena Bokemark Karin Manhem Kirsten Mehlig Björn Andersson 《The American journal of geriatric pharmacotherapy》2012,10(5):313-322
BackgroundAlthough treatment with statins has produced beneficial effects when used as secondary prevention, its primary protective role is still somewhat controversial. Moreover, few studies have evaluated the effect of statins in older patients with stroke.ObjectiveThe aim was to investigate whether treatment with statins decreases stroke severity and/or improves survival and outcome after stroke in an older population.MethodsWe investigated the association between previous statin use and stroke severity (National Institutes of Health Stroke Scale [NIHSS]), as well as the effect of poststroke statin treatment on 12-month functional outcome (modified Rankin Scale [mRS] score) in 799 patients (mean age, 78 years), with acute ischemic stroke. The effect of statin treatment on survival was examined using the Cox proportional hazard model, after adjusting for relevant covariates.ResultsStatins did not decrease stroke severity and did not improve 30-day survival. However, both the 12-month survival (hazard ratio = 0.33; 95% CI, 0.20–to 0.54; P < 0.001) and the 12-month functional outcome (odds ratio = 2.09; 95% CI, 1.25–3.52; P = 0.005) were significantly better in the group treated with statins.ConclusionsSignificantly better survival and functional outcome were noted with poststroke statins at the end of the 12-month follow-up period. Statins seem to provide beneficial effects for the long-term functional outcome and survival in the elderly. 相似文献